Press release
Idiopathic Pulmonary Fibrosis Market Size Predicted to Hit USD 6.16 billion by 2030 at 7.0% CAGR, Says AMR
Idiopathic Pulmonary Fibrosis Market
Increase in incidences of cancer worldwide, favorable reimbursement policies provided by manufacturers & insurance providers, and rise in cigarette smoking drive the growth of the global idiopathic pulmonary fibrosis market. However, the unavailability of the proper treatment options restrains the market growth. On the other hand, rise in number of pipeline drugs and untapped potential in developing countries present new opportunities in the coming years.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4315
๐๐จ๐ฉ ๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข AstraZeneca PLC
โข Bristol-Myers Squibb Company
โข Boehringer Ingelheim
โข GNI Group Ltd
โข F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
โข Shiongi co Ltd
โข Mission Therapeutics
โข Biogen, Inc.
โข Galapagos NV
โข FibroGen, Inc.
๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
By Drug Type
โข Pirfenidone
โข Nintedanib
By Distribution Channel
โข Hospital Pharmacies
โข Retail Pharmacies
โข Online Providers
Based on region, North America contributed to the highest market share in 2020, holding more than two-fifths of the global idiopathic pulmonary fibrosis market, and is projected to continue its lead in terms of revenue by 2030. This is attributed to high expenditure on R&D activities, the presence of major players & their product availability, and the well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 8.9% during the forecast period, owing to improvement in R&D facilities and rapidly developing economic conditions.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4407
Key Findings Of The Study
โข By drug type, the pirfenidone segment is expected to experience rapid growth in the idiopathic pulmonary fibrosis market, and is projected to grow at a CAGR of 7.2% from 2021 to 2030
โข Nintedanib is projected to grow at a CAGR of 6.6% during the forecast period.
โข Region-wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.9% during the forecast period.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Idiopathic Pulmonary Fibrosis Market Size Predicted to Hit USD 6.16 billion by 2030 at 7.0% CAGR, Says AMR here
News-ID: 3675429 • Views: โฆ
More Releases from Allied Market Research (AMR)
Europe IVD Market Size Predicted to Hit USD 18 Billion by 2027at 4.8% CAGR, Says โฆ
Allied Market Research has published a study report with the title ๐๐ฎ๐ซ๐จ๐ฉ๐ ๐๐ง ๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ (๐๐๐) ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ ๐ข๐ฌ ๐๐ง๐ญ๐ข๐๐ข๐ฉ๐๐ญ๐๐ ๐ญ๐จ ๐๐๐ซ๐ง๐๐ซ ๐๐๐ ๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐ ๐๐ญ ๐ ๐๐๐๐ ๐จ๐ ๐.๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐
๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐ซ๐ข๐จ๐. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source ofโฆ
Coronary Stents Market Size Predicted to Hit USD 15.4 billion by 2030 at 6 % CAG โฆ
A new business intelligence report released by Allied Market Research, the global Coronary Stents Market Size accounted for USD 8.8 billion in 2020, and it is estimated to surpass around USD 15.4 billion by 2030, registering a CAGR of 6% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance toโฆ
Ostomy Care and Accessories Market Outlook 2024: Growth Drivers and Strategic De โฆ
Allied Market Research Analyst have added a new research study on Title Ostomy Care and Accessories Market, Global Outlook and Forecast 2023-2032 with detailed information & Key Players Such as 3M Company, Alcare, B. Braun Melsungen, Clinimed Group (Welland Medical), Coloplast, Cymed Micro Skin, Hollister, ConvaTec, Nu-Hope Laboratories, Schweitzer-Mauduit International (Scapa Healthcare), Smith and Nephew, Torbot Group. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes,โฆ
Shoulder Arthroscopy Market Size Poised for Growth, Expected to Reach USD 712.12 โฆ
Allied Market Research published a report, titled, "Shoulder Arthroscopy Market by Product Type (Arthroscopes, Power Shaver Systems, Shoulder Arthroscopic Implants, Arthroscopic Systems, and Others), Indication (Rotator Cuff Tears, Shoulder Instability or Dislocation, Frozen Shoulder, Shoulder Impingement Syndrome, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Other): Global Opportunity Analysis and Industry Forecast, 2023-2032โณ. The shoulder arthroscopy market was valued at $432.46 million in 2022 and is estimated to reachโฆ
More Releases for Idiopathic
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,โฆ
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth โฆ
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. Inโฆ
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, โฆ
Global Idiopathic Scoliosis Treatmentโโโโโโโ Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatmentโโโโโโโ Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sampleโฆ
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, itโฆ
Juvenile Idiopathic Arthritis Therapeutics Market
JIA is also known as juvenile idiopathic arthritis and is the most common inflammatory arthritis of childhood, musculoskeletal pain is a common symptom in childhood and is usually benign and self-resolving. JIA is affected to children who are under age 17. Recognizing rare but treatable causes, including inflammatory, malignant and infectious etiologies, remains a constant challenge. According to the American College of Rheumatology, Juvenile idiopathic arthritis affects one in 1000โฆ
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipationโฆ
